According to BioMarin Pharmaceutical's latest financial reports the company's current revenue (TTM ) is $2.85 Billion USD. an increase over the revenue in the year 2023 that were of $2.41 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | $2.85 B | 17.97% |
2023 | $2.41 B | 15.42% |
2022 | $2.09 B | 13.53% |
2021 | $1.84 B | -0.76% |
2020 | $1.86 B | 9.18% |
2019 | $1.70 B | 14.27% |
2018 | $1.49 B | 13.52% |
2017 | $1.31 B | 17.62% |
2016 | $1.11 B | 25.5% |
2015 | $0.88 B | 18.54% |
2014 | $0.75 B | 36.88% |
2013 | $0.54 B | 9.54% |
2012 | $0.50 B | 13.45% |
2011 | $0.44 B | 17.3% |
2010 | $0.37 B | 15.9% |
2009 | $0.32 B | 9.5% |
2008 | $0.29 B | 143.86% |
2007 | $0.12 B | 44.38% |
2006 | $84.2 M | 228.05% |
2005 | $25.66 M | |
2002 | $13.91 M | 34.65% |
2001 | $10.33 M | -16.14% |
2000 | $12.32 M | 76.59% |
1999 | $6.98 M |